 T2 Biosystems Inc NASDAQ:TTOO announced that its T2SARS-CoV-2 Panel is capable of detecting the Mu B.1.621 and Iota B.1.526 variants, which were recently confirmed to be present in the U.S. Also Read: T2 Biosystems Q2 Earnings Edges Wall Street Estimates On Higher Test Panels Volumes, Expects Lower COVID-19 Test Sales In FY21. 